mail
versión imprimible
 
 

4th Tumor Myeloid Targeting Therapies Summit 2024

Evvnt Promotion / evvnt
Archivo
-
11.06.2024 - 13.06.2024  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 8:00 AM - 5:00 PM
 
Temas de la conferencia
The landscape of innate immune cells is rapidly advancing towards clinical applications. Multiple published studies in the last year repeatedly affirm that targeting myeloid cells rather than the cancer cells themselves can shrink tumors, further providing confidence in their potential as a clinically effective therapeutic.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/2219781-3?pid=4832

Speakers: Akshata Udyavar, Senior Director, Actym Therapeutics, Peter Ellmark, CSO, Alligator Bioscience, Stephanie Casey Parks, Principal Scientist, Amgen, and more
 

Información e inscripción:

https://go.evvnt.com/2219781-2?pid=4832
Mr. Luke Kelly
 
Categorías
Oncología
Idioma
Inglés
Cuota del Congreso
USD 2199.00 - USD 5097.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Österreichisches Rotes KreuzHelix - Forschung & Beratung WienÄrztekammer für WienEuropean Public Health Association (EUPHA)Österreichische Akademie der ÄrzteEuropean Health Forum GasteinÄrzte der WeltCenter of Excellence